168 related articles for article (PubMed ID: 10699972)
1. Decreased accumulation of [14C]carboplatin in human cisplatin-resistant cells results from reduced energy-dependent uptake.
Shen DW; Goldenberg S; Pastan I; Gottesman MM
J Cell Physiol; 2000 Apr; 183(1):108-16. PubMed ID: 10699972
[TBL] [Abstract][Full Text] [Related]
2. Cross-resistance to methotrexate and metals in human cisplatin-resistant cell lines results from a pleiotropic defect in accumulation of these compounds associated with reduced plasma membrane binding proteins.
Shen D; Pastan I; Gottesman MM
Cancer Res; 1998 Jan; 58(2):268-75. PubMed ID: 9443404
[TBL] [Abstract][Full Text] [Related]
3. Transport of cisplatin and bis-acetato-ammine-dichlorocyclohexylamine Platinum(IV) (JM216) in human ovarian carcinoma cell lines: identification of a plasma membrane protein associated with cisplatin resistance.
Sharp SY; Rogers PM; Kelland LR
Clin Cancer Res; 1995 Sep; 1(9):981-9. PubMed ID: 9816070
[TBL] [Abstract][Full Text] [Related]
4. Identification of cytoskeletal [14C]carboplatin-binding proteins reveals reduced expression and disorganization of actin and filamin in cisplatin-resistant cell lines.
Shen DW; Liang XJ; Gawinowicz MA; Gottesman MM
Mol Pharmacol; 2004 Oct; 66(4):789-93. PubMed ID: 15385639
[TBL] [Abstract][Full Text] [Related]
5. Establishment and characterization of an acquired cisplatin-resistant subline in a human osteosarcoma cell line.
Asada N; Tsuchiya H; Ueda Y; Tomita K
Anticancer Res; 1998; 18(3A):1765-8. PubMed ID: 9673402
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation and altered localization of gamma-catenin in cisplatin-resistant adenocarcinoma cells.
Liang XJ; Shen DW; Gottesman MM
Mol Pharmacol; 2004 May; 65(5):1217-24. PubMed ID: 15102950
[TBL] [Abstract][Full Text] [Related]
7. The role of platinum uptake and glutathione levels in L1210 cells sensitive and resistant to cisplatin, tetraplatin or carboplatin.
Nicolson MC; Orr RM; O'Neill CF; Harrap KR
Neoplasma; 1992; 39(3):189-95. PubMed ID: 1528325
[TBL] [Abstract][Full Text] [Related]
8. Multiple mechanisms confer drug resistance to mitoxantrone in the human 8226 myeloma cell line.
Hazlehurst LA; Foley NE; Gleason-Guzman MC; Hacker MP; Cress AE; Greenberger LW; De Jong MC; Dalton WS
Cancer Res; 1999 Mar; 59(5):1021-8. PubMed ID: 10070958
[TBL] [Abstract][Full Text] [Related]
9. Novel mechanisms of platinum drug resistance identified in cells selected for resistance to JM118 the active metabolite of satraplatin.
Samimi G; Kishimoto S; Manorek G; Breaux JK; Howell SB
Cancer Chemother Pharmacol; 2007 Feb; 59(3):301-12. PubMed ID: 16770583
[TBL] [Abstract][Full Text] [Related]
10. A pleiotropic defect reducing drug accumulation in cisplatin-resistant cells.
Liang XJ; Shen DW; Gottesman MM
J Inorg Biochem; 2004 Oct; 98(10):1599-606. PubMed ID: 15458822
[TBL] [Abstract][Full Text] [Related]
11. Codominance of cisplatin resistance in somatic cell hybrids.
Ying YL; Shen DW; Liang XJ; Gottesman MM
J Cell Physiol; 2003 Jul; 196(1):63-9. PubMed ID: 12767041
[TBL] [Abstract][Full Text] [Related]
12. Altered cytotoxicity of (2-chloroethyl)-3-sarcosinamide-1-nitrosourea in human glioma cell lines SK-MG-1 and SKI-1 correlates with differential transport kinetics.
Noë AJ; Malapetsa A; Panasci LC
Cancer Res; 1994 Mar; 54(6):1491-6. PubMed ID: 8137253
[TBL] [Abstract][Full Text] [Related]
13. Modulation of the cellular pharmacology of JM118, the major metabolite of satraplatin, by copper influx and efflux transporters.
Samimi G; Howell SB
Cancer Chemother Pharmacol; 2006 Jun; 57(6):781-8. PubMed ID: 16170571
[TBL] [Abstract][Full Text] [Related]
14. Comparison of lipid content, surface membrane fluidity, and temperature dependence of cis-diamminedichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cells.
Mann SC; Andrews PA; Howell SB
Anticancer Res; 1988; 8(6):1211-5. PubMed ID: 3218956
[TBL] [Abstract][Full Text] [Related]
15. Different accumulation of cisplatin, oxaliplatin and JM216 in sensitive and cisplatin-resistant human cervical tumour cells.
Martelli L; Di Mario F; Ragazzi E; Apostoli P; Leone R; Perego P; Fumagalli G
Biochem Pharmacol; 2006 Sep; 72(6):693-700. PubMed ID: 16844093
[TBL] [Abstract][Full Text] [Related]
16. Contribution of the major copper influx transporter CTR1 to the cellular accumulation of cisplatin, carboplatin, and oxaliplatin.
Holzer AK; Manorek GH; Howell SB
Mol Pharmacol; 2006 Oct; 70(4):1390-4. PubMed ID: 16847145
[TBL] [Abstract][Full Text] [Related]
17. [Establishment of a human nasopharyngeal carcinoma drug-resistant cell line CNE2/DDP and screening of drug-resistant genes].
Jiang RD; Zhang LX; Yue W; Zhu YF; Lu HJ; Liu X; Cen XT; Guan XY; Li CH
Ai Zheng; 2003 Apr; 22(4):337-45. PubMed ID: 12703984
[TBL] [Abstract][Full Text] [Related]
18. Mislocalization of membrane proteins associated with multidrug resistance in cisplatin-resistant cancer cell lines.
Liang XJ; Shen DW; Garfield S; Gottesman MM
Cancer Res; 2003 Sep; 63(18):5909-16. PubMed ID: 14522917
[TBL] [Abstract][Full Text] [Related]
19. Role of Na+, K+-ATPase alpha1 subunit in the intracellular accumulation of cisplatin.
Kishimoto S; Kawazoe Y; Ikeno M; Saitoh M; Nakano Y; Nishi Y; Fukushima S; Takeuchi Y
Cancer Chemother Pharmacol; 2006 Jan; 57(1):84-90. PubMed ID: 16044341
[TBL] [Abstract][Full Text] [Related]
20. Single cell analysis of daunomycin uptake and efflux in multidrug-resistant and -sensitive KB cells: effects of verapamil and other drugs.
Willingham MC; Cornwell MM; Cardarelli CO; Gottesman MM; Pastan I
Cancer Res; 1986 Nov; 46(11):5941-6. PubMed ID: 3756931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
